Ik-Joo Chung

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Sung Hoon Noh, Sook Ryun Park, Han‐Kwang Yang et al. · The Lancet Oncology · 2014 · 1.1K citations · Full text

Medicine, Oncology, Surgery +15

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial

Yong Sang Hong, Young Suk Park, Ho Yeong Lim et al. · The Lancet Oncology · 2012 · 132 citations

Medicine, Oncology, Chemotherapy +9

S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial

Yoon‐Koo Kang, Keisho Chìn, Hyun Cheol Chung et al. · The Lancet Oncology · 2020 · 77 citations · Full text

Medicine, Oncology, Pharmacology +11

Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial

Jin Won Kim, Sae Won Han, Ik-Joo Chung et al. · European Journal of Cancer · 2020 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist

Thanh Nhan Nguyen Pham, Cheol Yi Hong, Jung-Joon Min et al. · Experimental & Molecular Medicine · 2010 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17